Abstract | BACKGROUND: The treatment of bipolar depression represents a relatively understudied area in clinical psychiatry. The depressive phases of bipolar disorder can be very disabling, with significant associated comorbidity and suicide risk, impairment in functioning, and infringement on quality of life. We review the current evidence for the management of bipolar depression. METHOD: RESULTS: CONCLUSIONS: Although the treatment of bipolar depression can be a complicated clinical task, the treatment armamentarium is expanding. Further research, especially in the form of randomized controlled trials, is warranted. Clinicians should be familiar with general guidelines for the use of psychopharmacologic agents for treating bipolar depression.
|
Authors | M T Compton, C B Nemeroff |
Journal | The Journal of clinical psychiatry
(J Clin Psychiatry)
Vol. 61 Suppl 9
Pg. 57-67
( 2000)
ISSN: 0160-6689 [Print] United States |
PMID | 10826663
(Publication Type: Journal Article, Review)
|
Chemical References |
- Anticonvulsants
- Antidepressive Agents
- Serotonin Uptake Inhibitors
- Bupropion
- Lithium
|
Topics |
- Anticonvulsants
(therapeutic use)
- Antidepressive Agents
(therapeutic use)
- Bipolar Disorder
(drug therapy, psychology, therapy)
- Bupropion
(therapeutic use)
- Combined Modality Therapy
- Electroconvulsive Therapy
- Humans
- Lithium
(therapeutic use)
- Phototherapy
- Psychotherapy
- Selective Serotonin Reuptake Inhibitors
(therapeutic use)
- Sleep Deprivation
- Treatment Outcome
|